LRRC32 and neoplasm: To further confirm the active targeting of GARP+ Tregs by our probe in vivo, we demonstrate that the tumour uptake of [111In]In-DOTAGA-GARP is significantly decreased in 4T1 tumours in Nude mice lacking Tregs compared to Balb/C mice (Supplemental Fig. 4).